Status:
UNKNOWN
Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders
Lead Sponsor:
Eugonia
Conditions:
Infertility
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
Detailed Description
Urinary human chorionic gonadotrophin (u-hCG) has been widely used to induce final oocyte maturation and to trigger ovulation in assisted conception. Recombinant technology has allowed the production ...
Eligibility Criteria
Inclusion
- At least 14 follicles \>11mm on the day of triggering final oocyte maturation
- Pretreated with GnRH antagonist protocol
Exclusion
- Poor responders
- Women with 25 or more follicles on the day of trigger
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00415766
Start Date
June 1 2013
End Date
July 1 2016
Last Update
January 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eugonia
Athens, Greece, 11528